FDA Inspection
Gojo IndustriesGojo Industries – FDA Inspection, Aug 5, 2022
Record Details
This FDA Inspection record concerns Gojo Industries, with an inspection on August 5, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Gojo Industries
- Inspection Date
- August 5, 2022
- Product Type
- Drugs
View Company Profile
ID · 3fe73cd2-c25f-4ae3-9aae-74aab58a8234
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1177254
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
3- 21 CFR 211.160(a)Following/documenting laboratory controls
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.194(a)(8)Second person sign off
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Gojo Industries
1| Date | Classification | Office | Project area |
|---|---|---|---|
| November 7, 2025 | VAI | Cincinnati District Office | Drug Quality Assurance |
Other documents for Gojo Industries
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.